Clinical trial
Prognostic Value of the Atherogenic Index of Plasma(AIP)for Cardiovascular Outcomes in Patients With Atrial Fibrillation
NCT05973474 is registered in ClinicalTrials.gov with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Value of the Atherogenic Index of Plasma(AIP)for Cardiovascular Outcomes in Patients With Atrial Fibrillation
- Lead sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 30, 2023
- Completion date
- July 31, 2024
- Enrollment
- 5,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
atrium; fibrillation, cardiovascular diseases, event, cardiac, lipid metabolism disorders